DoW Breast Cancer, Breakthrough Award Levels 1 and 2

In plain English

Defense Health Agency Contracting Activity - DHACA (Department of Defense) is accepting applications for this grant until Nov 18, 2026 (7 days left).

The agency expects to make 6 awards and estimated total program funding is $10,600,000.

Eligibility is listed as unrestricted (open to any type of applicant), subject to any clarification in the listing.

The listing says cost sharing or matching is not required.

Built only from the fields in the Grants.gov listing. Always confirm on the official listing.

• Unrestricted (open to any type of entity above, subject to clarification in the listing)

Excerpt from the official synopsis on Grants.gov (shortened; read the full text on the official listing):

Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Breakthrough Award mechanism supports promising research with high potential to lead to or make breakthroughs in breast cancer. All applications must address at least one of the FY26 BCRP overarching challenges or provide adequate justification for exception. Applications must address the challenge in a way that can lead to a breakthrough and have major impact. The FY26 Breakthrough Award mechanism contains four different funding levels designed to support major (but not all) stages of research that will lead to clinical application. Each level specifies a distinct research scope. This program announcement discusses the Breakthrough Award Levels 1 and 2. Distinctive Features: * This funding mechanism allows for applications submitted under Funding Level 1 or Funding Level 2. …

Read the full listing on Grants.gov →